Acute Kidney Injury (AKI) Phase I
Written and Reviewed by: SDG
Completed and published in BMC Nephrology, the Phase I human clinical trial, conducted in partnership with Massachusetts General Hospital, enabled the FDA approval of an Investigational New Drug application for Basis and the AKI Phase II trial. Publication here. ClinicalTrials.gov Identifier: NCT03176628
